Category:
Life Sciences
Client:
Qu Biologics
Qu Biologics
Qu Biologics was founded in 2007 by physician Dr. Hal Gunn and businessman and cancer survivor Rob Freeman. The company’s vision began with a desire to develop treatments that re-establish health by restoring the body’s normal immune function and innate capacity to heal. This vision continues to guide us today. Qu Biologics’ Site Specific Immunomodulators (SSIs) are designed to stimulate activated innate immune cell recruitment to the targeted organ or tissue to restore immune function and treat a range of chronic diseases, including cancer and inflammatory bowel disease.
